Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
about
CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive VaccinesCationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigensEvaluation of combinatorial vaccines against anthrax and plague in a murine modelImmune defense against pneumonic plagueIntranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategiesAntigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules.Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challengeProtection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in MiceCurrent challenges in the development of vaccines for pneumonic plague.Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens.Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccineDifferent pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.NSOM- and AFM-based nanotechnology elucidates nano-structural and atomic-force features of a Y. pestis V immunogen-containing particle vaccine capable of eliciting robust response.Prospects for new plague vaccines.Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint.Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.Validation of quantitative ELISAS for measuring anti-Yersinia pestis F1 and V antibody concentrations in nonhuman primate sera.Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system.The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
P2860
Q27014949-9F240F3C-5A7E-4ED3-B32A-95453F35C2F5Q27310007-AD0993C1-A037-474B-9181-3784BEE5F8FFQ33283821-ADB46C12-442F-4293-8688-682C7C0C2EA9Q33584403-78F13381-CDF6-4D15-B752-960868F81A17Q33613442-FD02DEA4-EBE9-4415-BC40-827805AB09D7Q33698142-C3163330-DDB8-47B0-8A93-1D91ED4B7DEAQ33768409-50F1E10D-F7D2-4EA9-BA6F-EA87D2B8024EQ33786763-5E79E1B4-3F3D-4289-AD1B-C364DC8BBE5FQ34016105-D8EEDC9A-2443-4882-A019-B2D8EC895C88Q34250117-9A9D4C04-D271-45D2-9F37-3D69E0A90021Q34348619-E444E81D-50BC-4472-B665-561975EE08FBQ34819434-E91FEBC8-946B-4184-B97B-817D3AEFAB62Q35066293-920E28EA-088F-4CB8-9A1F-1EE5F8FF3C4CQ36237899-5379B5EC-A367-4322-8B7E-4F41DF114195Q36620684-4EA3F607-8D3C-43A1-8BCA-3A87DCA12C8CQ36628038-82E5A3C0-E307-44AD-877D-0A033BA804D1Q36744330-9464BF69-9153-4942-8920-ED94FF3C45E4Q36804213-7522A391-11BD-4E99-B573-5C655ACB1740Q36852090-1F23AE98-39E8-4579-8E9A-981840073C87Q36881875-C5E1C82A-A1BD-466B-A813-5536819E3767Q36960814-B1DCD689-4124-4270-8028-71C65AB1758DQ37144984-4241B647-6362-48BE-AEA7-26BE6EEA3A60Q37344602-C979008E-1571-4CD7-B1CF-E923A9FE1AE3Q37640118-BAE504FC-35A6-404E-87EC-BF04AE68902CQ37673260-D4D2882D-AE60-43E2-879E-BFD1CA982BCDQ41418787-9A1DCD56-7180-4062-945C-AA544E43F8BAQ41421634-488FC4FB-3367-4506-BDD6-B35433EE4148Q41439514-3C16F2E1-7CB1-463A-BC62-52A0BB8DCB20Q57945015-CC674DB5-F208-4642-ADBE-6125210068CB
P2860
Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Protection against aerosolized ...... h recombinant plague antigens.
@ast
Protection against aerosolized ...... h recombinant plague antigens.
@en
type
label
Protection against aerosolized ...... h recombinant plague antigens.
@ast
Protection against aerosolized ...... h recombinant plague antigens.
@en
prefLabel
Protection against aerosolized ...... h recombinant plague antigens.
@ast
Protection against aerosolized ...... h recombinant plague antigens.
@en
P2093
P2860
P1476
Protection against aerosolized ...... th recombinant plague antigens
@en
P2093
Audrey Glynn
Bradford S Powell
John D Clements
Lucy C Freytag
P2860
P304
P356
10.1128/IAI.73.8.5256-5261.2005
P407
P577
2005-08-01T00:00:00Z